Fri, Aug 22, 2014, 10:43 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

  • racavalli racavalli Oct 18, 2013 1:20 PM Flag

    FDA clock ticking fast and new big buyers running out of time and may miss big move

    Anything can happen at the FDA meeting on Oct 29, but the highest probability is that they will designate Ampion a "Breakthrough Treatment" simply because the actual trial data demonstrates that it really is.

    Ampio lacks the endorsement of a big banker to spread all their good news but this will partially be offset with the FDA declaration of Ampion being a "Breakthrough Treatment".

    If that happens, this good news won't need a big banker to get shares to explode because word will be delivered to the desk of every investor and institution on the planet . . . without a banker. Shares will soar because it will be a huge surprise and breakthrough to mainstream Wall Street.

    The implications of Ampion are immense and far beyond the imagination of even the most bullish AMPE supporters.

    An FDA designation of "Breakthrough Therapy" for Ampion is not certain, but it is obviously a very high probability.

    Watch for shares to start running on big volume very soon as shorts and big buyers clash while they are driven by the 10/29 clock.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AMPE
4.84-0.82(-14.49%)Aug 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Keurig Green Mountain, Inc.
NasdaqGSFri, Aug 22, 2014 4:00 PM EDT
Salesforce.com, Inc
NYSEFri, Aug 22, 2014 4:00 PM EDT